Jefferies Financial Group’s 10x Genomics TXG Stock Holding History

Jefferies Financial Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Sell	29,000 -26,800	-48%	-$702K	0.01%	924
2026 Q1	$1.18M	Buy	55,800 +41,501	+290%	+$830K	0.01%	857
2025 Q4	$233K	Buy	+14,299	New	+$216K	﹤0.01%	1573
2025 Q3	–	Sell	-34,000	Closed	-$394K	–	1687
2025 Q2	$394K	Sell	34,000 -37,425	-52%	-$341K	﹤0.01%	957
2025 Q1	$624K	Buy	71,425 +40,377	+130%	+$509K	0.01%	983
2024 Q4	$446K	Sell	31,048 -284,000	-90%	-$4.48M	﹤0.01%	1138
2024 Q3	$7.11M	Buy	+315,048	New	+$6.51M	0.05%	241
2023 Q4	–	Sell	-6,186	Closed	-$255K	–	2006
2023 Q3	$255K	Buy	+6,186	New	+$322K	﹤0.01%	1276

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jefferies Financial Group's TXG Position: Q2 2026 in Review

Jefferies Financial Group reduced its 10x Genomics (TXG) stake by 48% in Q2 2026, selling an estimated $702K and leaving 29,000 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #924.

Jefferies Financial Group first reported a position in TXG in Q3 2023 and has held it in 8 quarters since. The position peaked at $7.11M in Q3 2024. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Jefferies Financial Group held 29,000 shares of 10x Genomics worth $1.11M as of Q2 2026.
Jefferies Financial Group sold 26,800 10x Genomics shares in Q2 2026, an estimated $702K.
10x Genomics made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #924 holding.
Jefferies Financial Group first reported a position in 10x Genomics in Q3 2023 and has held it in 8 quarters since.
Jefferies Financial Group's 10x Genomics position peaked at $7.11M in Q3 2024.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.